Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-02

Clinical Trial Update: The Effect of Cilostazol on Rheumatoid Arthritis Patients [Phase 2, Phase 3]

View source ↗

Summary

The trial update reports completion of Phase 2 and Phase 3 studies evaluating cilostazol in patients with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pletal (cilostazol)

Snippet

Sponsor: Ain Shams University | Conditions: Rheumatoid Arthritis | Phase 2, Phase 3 | Status: COMPLETED